13
43
Growth Score
-6 pts
Heat Score
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
262658
Phenaros merged with DefiniGEN to form pixlbio in 2025
About the Company
pixlbio is a TechBio company combining human iPSC-derived cell models with AI-powered phenomics for drug discovery and safety research. Formed in 2025 from the merger of DefiniGEN — a pioneer in iPSC-derived hepatocyte technology founded at the University of Cambridge — and Phenaros, a Swedish AI phenomics company. pixlbio supplies iPSC-derived
hepatocytes (pixHep), stellate cells (pixStellate), intestinal organoids (pixIO), and disease models for MASLD, A1ATD, PFIC2, and urea cycle disorders, alongside Cell Painting phenomics and end-to-end drug discovery services. Trusted by numerous global pharmaceutical companies including AstraZeneca and Sanofi.
